{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1390282679885920128.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.11213/tonyobyo.60.783"}},{"identifier":{"@type":"NAID","@value":"130006295175"}},{"identifier":{"@type":"URI","@value":"https://search.jamas.or.jp/link/ui/2018110046"}}],"dc:title":[{"@language":"ja","@value":"糖尿病患者におけるポリファーマシーの実態，及び週1回の経口血糖降下薬を希望する患者背景についての検討"},{"@language":"en","@value":"A Survey on the Current Situation of Polypharmacy in Diabetes Patients and the Characteristics of Those Who Prefer a Once-Weekly Oral Hypoglycemic Agent"}],"dc:language":"ja","description":[{"type":"abstract","notation":[{"@language":"en","@value":"<p>This study aimed to survey the current situation of polypharmacy and the characteristics of patients under diabetic treatment who prefer a once-weekly oral hypoglycemic agent (OHA). Among 520 outpatients who were receiving diabetic treatment in our hospital (age, 67±11 years; HbA1c, 7.0±0.8 %; Duration of diabetes, 14±9 years), 413 (79 %) were treated with multiple agents. A multivariate logistic regression analysis revealed that age (OR 1.03 [1.00-1.05]), diabetes duration (OR 1.05 [1.01-1.08]), HbA1c (OR 1.63 [1.15-2.31]), hypertension (OR 10.25 [5.15-20.41]), and the number of clinical departments (OR 1.93 [1.47-2.54]) were independent predictors of polypharmacy. A questionnaire survey revealed that 73 % of the patients preferred a once-weekly OHA, and that the patients who preferred a once-weekly OHA were significantly younger, were more often male, and used more types of medication for diabetes than those who did not prefer a once-weekly OHA. These findings suggest that polypharmacy is prevalent in diabetic patients. In addition, the percentage of patients who preferred once-weekly OHA was high. Furthermore, this patient group was younger, showed a male predominance, and used several types of diabetes medications.</p>"},{"@language":"ja","@value":"<p>薬物療法中の糖尿病患者を対象に，ポリファーマシーの実態および週1回の経口血糖降下薬を希望する患者の背景因子を調査した．520例中（年齢67±11歳，HbA1c7.0±0.8 %，糖尿病罹病期間14±9年）79 %がポリファーマシーに該当し，年齢（OR 1.03），糖尿病罹病期間（OR 1.05），HbA1c（OR 1.63），高血圧合併（OR 10.25），通院診療科数（OR 1.93）がポリファーマシーの独立した関連因子として抽出された．経口血糖降下薬のうち，週1回製剤への変更を22 %が「大いに希望する」，51 %が「希望する」，28 %が「希望しない」と回答．希望する群は希望しない群と比較し有意に年齢が若く，男性が多く，糖尿病治療薬の種類が多かった．本検討から糖尿病患者ではポリファーマシー率が高く，週1回製剤の希望者は少なくはなく，その特徴として若年，男性，糖尿病治療薬数が多いことが示された．</p>"}],"abstractLicenseFlag":"disallow"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1410282679885920129","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000378124399"}],"foaf:name":[{"@language":"ja","@value":"入江 陽子"},{"@language":"en","@value":"Irie Yoko"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Diabetes and Endocrinology, Osaka Police Hospital"},{"@language":"ja","@value":"大阪警察病院糖尿病・内分泌内科"}]},{"@id":"https://cir.nii.ac.jp/crid/1410282679885920136","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000378124400"}],"foaf:name":[{"@language":"ja","@value":"片岡 隆太郎"},{"@language":"en","@value":"Kataoka Ryutaro"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Diabetes and Endocrinology, Osaka Police Hospital"},{"@language":"ja","@value":"大阪警察病院糖尿病・内分泌内科"}]},{"@id":"https://cir.nii.ac.jp/crid/1410282679885920134","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000378124401"}],"foaf:name":[{"@language":"ja","@value":"大楠 崇浩"},{"@language":"en","@value":"Okusu Takahiro"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Diabetes and Endocrinology, Osaka Police Hospital"},{"@language":"ja","@value":"大阪警察病院糖尿病・内分泌内科"}]},{"@id":"https://cir.nii.ac.jp/crid/1410282679885920135","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000378124402"}],"foaf:name":[{"@language":"ja","@value":"白木 梓"},{"@language":"en","@value":"Shiraki Azusa"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Diabetes and Endocrinology, Osaka Police Hospital"},{"@language":"ja","@value":"大阪警察病院糖尿病・内分泌内科"}]},{"@id":"https://cir.nii.ac.jp/crid/1410282679885920130","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000378124403"}],"foaf:name":[{"@language":"ja","@value":"竹本 有里"},{"@language":"en","@value":"Takemoto Yuri"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Diabetes and Endocrinology, Osaka Police Hospital"},{"@language":"ja","@value":"大阪警察病院糖尿病・内分泌内科"}]},{"@id":"https://cir.nii.ac.jp/crid/1410282679885920131","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000378124404"}],"foaf:name":[{"@language":"ja","@value":"秦 誠倫"},{"@language":"en","@value":"Hata Son-yun"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Diabetes and Endocrinology, Osaka Police Hospital"},{"@language":"ja","@value":"大阪警察病院糖尿病・内分泌内科"}]},{"@id":"https://cir.nii.ac.jp/crid/1410282679885920133","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000378124405"}],"foaf:name":[{"@language":"ja","@value":"藤井 浩平"},{"@language":"en","@value":"Fujii Kouhei"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Diabetes and Endocrinology, Osaka Police Hospital"},{"@language":"ja","@value":"大阪警察病院糖尿病・内分泌内科"}]},{"@id":"https://cir.nii.ac.jp/crid/1410282679885920132","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000378124406"}],"foaf:name":[{"@language":"ja","@value":"永田 慎平"},{"@language":"en","@value":"Nagata Shinpei"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Diabetes and Endocrinology, Osaka Police Hospital"},{"@language":"ja","@value":"大阪警察病院糖尿病・内分泌内科"}]},{"@id":"https://cir.nii.ac.jp/crid/1410282679885920128","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000378124407"}],"foaf:name":[{"@language":"ja","@value":"安田 哲行"},{"@language":"en","@value":"Yasuda Tetsuyuki"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Diabetes and Endocrinology, Osaka Police Hospital"},{"@language":"ja","@value":"大阪警察病院糖尿病・内分泌内科"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"0021437X"},{"@type":"EISSN","@value":"1881588X"}],"prism:publicationName":[{"@language":"en","@value":"Journal of the Japan Diabetes Society"},{"@language":"ja","@value":"糖尿病"},{"@language":"ja","@value":"糖尿病"},{"@language":"en","@value":"Journal of the Japan Diabetes Society"}],"dc:publisher":[{"@language":"en","@value":"THE JAPAN DIABETES SOCIETY"},{"@language":"ja","@value":"一般社団法人 日本糖尿病学会"}],"prism:publicationDate":"2017","prism:volume":"60","prism:number":"12","prism:startingPage":"783","prism:endingPage":"790"},"url":[{"@id":"https://search.jamas.or.jp/link/ui/2018110046"}],"availableAt":"2017","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=%E3%83%9D%E3%83%AA%E3%83%95%E3%82%A1%E3%83%BC%E3%83%9E%E3%82%B7%E3%83%BC%EF%BC%88%E8%A8%98%E8%BC%89%E3%81%AA%E3%81%97%EF%BC%89","dc:title":"ポリファーマシー（記載なし）"},{"@id":"https://cir.nii.ac.jp/all?q=%E9%80%B11%E5%9B%9E%E8%A3%BD%E5%89%A4%EF%BC%88%E8%A8%98%E8%BC%89%E3%81%AA%E3%81%97%EF%BC%89","dc:title":"週1回製剤（記載なし）"},{"@id":"https://cir.nii.ac.jp/all?q=%E3%82%A2%E3%83%89%E3%83%92%E3%82%A2%E3%83%A9%E3%83%B3%E3%82%B9","dc:title":"アドヒアランス"},{"@id":"https://cir.nii.ac.jp/all?q=DPP-4%E9%98%BB%E5%AE%B3%E8%96%AC","dc:title":"DPP-4阻害薬"}],"dataSourceIdentifier":[{"@type":"JALC","@value":"oai:japanlinkcenter.org:2003548479"},{"@type":"CIA","@value":"130006295175"}]}